Drugs / Meningococcal (Groups A and C) Polysaccharide Vaccine
Meningococcal (Groups A and C) Polysaccharide Vaccine
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT01430611 Comparator | Aug 2011 → Aug 2012 | meningitis, meningococcal infection | Sanofi Pasteur, a Sanofi Company | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Meningococcal (Groups A and C) Polysaccharide Vaccine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01430611 ↗ |
| Modality | Vaccine | “Meningococcal (Groups A and C) Polysaccharide Vaccine” NCT01430611 ↗ |